课题基金 / 基金详情

Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis – a pragmatic, randomized, controlled trial

Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis – a pragmatic, randomized, controlled trial
己酮可可碱能否改善患有迟发性败血症或坏死性小肠结肠炎的早产儿的长期结局——一项务实、随机、对照试验
批准号:
nhmrc : 1105322
负责人:
A/Pr Tobias Strunk
金额:
$199.64万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 2020-12-31

项目摘要

项目成果

A/Pr Tobias Strunk的其他基金

相似基金

相关文献

中文摘要
翻译
早产儿死亡和残疾的风险很高。脑损伤通常是由感染或肠道疾病引起的炎症造成的。到目前为止,还没有治疗方法来减少炎症的有害影响。己酮可可碱减少炎症,是早产儿的一种有前途的、安全的、廉价的治疗选择。这项研究将确定己酮可可碱在抗生素的基础上是否能提高早产儿的存活率而不致残。
英文摘要
Very preterm infants are at high risk of death and disability. Brain injury is often the result of inflammation caused by infection or bowel disease. To date, there is no treatment to reduce the harmful effects of inflammation. Pentoxifylline reduces inflammation and is a promising, safe and inexpensive treatment option for preterm infants. This study will determine whether Pentoxifylline in addition to antibiotics improves survival without disability in preterm infants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis – a pragmatic, randomized, controlled trial
  • 批准号:
    nhmrc : GNT1105322
  • 项目类别:
    Project Grants
  • 资助金额:
    $290.11万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Tobias Strunk
  • 依托单位:
海外基金